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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for pantothenic acid
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) derived Dietary Reference Values (DRVs) for pantothenic acid. Pantothenic acid is a water-soluble 
vitamin, which is a component of coenzyme A (CoA) and acyl-carrier proteins. Pantothenic acid is ubiquitous 
and deficiency is rare. There are no suitable biomarkers that can be used to derive the requirement for 
pantothenic acid. Data available on pantothenic acid intakes and health consequences are very limited and cannot 
be used to derive DRVs for pantothenic acid. As there is insufficient evidence available to derive an Average 
Requirement and a Population Reference Intake, an Adequate Intake (AI) is proposed. The setting of AIs is based 
on observed pantothenic acid intakes with a mixed diet and the apparent absence of signs of deficiency in the EU, 
suggesting that current intake levels are adequate. The AI for adults is set at 5 mg/day. The AI for adults also 
applies to pregnant women. For lactating women, an AI of 7 mg/day is proposed, to compensate for pantothenic 
acid losses through breast milk. For infants over six months, an AI of 3 mg/day is proposed by extrapolating from 
the pantothenic acid intake of exclusively breast-fed infants aged zero to six months, using allometric scaling and 
reference body weight for each age group, in order to account for the role of pantothenic acid in energy 
metabolism. The AI for children and adolescents is set at 4 and 5 mg/day, respectively, based on observed 
intakes in the EU.  
© European Food Safety Authority, 2014 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values (DRVs) 
for the European population, including pantothenic acid.  
In 1993, the Scientific Committee for Food (SCF) proposed an Acceptable Range of Intakes of 
pantothenic acid for adults of 3–12 mg/day, based on observed intakes of pantothenic acid in 
European countries, which were considered adequate to meet requirements and prevent deficiency.  
Pantothenic acid is a water-soluble vitamin, which is a component of coenzyme A (CoA) and acyl-
carrier proteins. Pantothenic acid is ubiquitous and deficiency is rare. Foods rich in pantothenic acid 
include meat (products), eggs, nuts, avocados and cruciferous vegetables. The main contributors to 
pantothenic acid intakes include meat products, bread, milk-based products and vegetables.  
Data on pantothenic acid absorption are lacking. Most of the pantothenic acid in tissues is present as 
CoA, mainly found in mitochondria, with lesser amounts present as acyl-carrier protein and free 
pantothenic acid. Pantothenic acid is excreted in urine, after hydrolysis of CoA in a multistep 
reaction.  
Urinary excretion of pantothenic acid and, to a lesser extent, pantothenic acid concentration in whole 
blood or erythrocytes reflect pantothenic acid intake. Data from the general population are limited so 
that the variability characteristics of these biomarkers and their ability to discriminate between 
pantothenic acid insufficiency and adequacy are not well known. No cut-off values have been 
established for these biomarkers. The Panel considers that there are no suitable biomarkers that can be 
used to derive the Average Requirement (AR) for pantothenic acid. 
Data available on pantothenic acid intakes and health consequences are very limited and cannot be 
used for deriving DRVs for pantothenic acid. 
As the evidence to derive an AR and thus a Population Reference Intake is considered insufficient, an 
Adequate Intake (AI) is proposed for all population groups. There is no indication that the AI should 
differ according to sex. The setting of AIs is based on observed pantothenic acid intakes with a mixed 
diet and the apparent absence of signs of deficiency in the EU, suggesting that current intake levels 
are adequate. Estimates of pantothenic acid intakes in children and adolescents, adults and older 
adults were available from eight EU countries. In boys and girls (3–12 years), mean/median intakes of 
3.0 to 5.7 mg/day were reported, while mean/median intakes of 3.0 to 7.2 mg/day were observed in 
adolescent boys and girls (11–19 years). In adult men and women below about 65 years, mean/median 
intakes of 3.2 to 6.3 mg/day were reported, while mean/median intakes were between 2.2 and 
6.0 mg/day in older men and women. Data on pantothenic acid intakes in pregnancy were scarce. 
The AI for adults is set at 5 mg/day. The AI for adults also applies to pregnant women. For lactating 
women, an AI of 7 mg/day is proposed, to compensate for pantothenic acid losses through breast milk. 
For infants over six months, an AI of 3 mg/day is proposed by extrapolating from the pantothenic acid 
intake of exclusively breast-fed infants aged zero to six months, using allometric scaling (body weight 
to the power of 0.75) and reference body weight for each age group, in order to account for the role of 
pantothenic acid in energy metabolism, and rounding to the nearest unit. The AIs for children and 
adolescents are set at 4 and 5 mg/day, respectively, based on observed intakes in the EU.  
Dietary Reference Values for pantothenic acid 
 
EFSA Journal 2014;12(2):3581 3 
TABLE OF CONTENTS 
Abstract ............................................................................................................................................................ 1 
Summary .......................................................................................................................................................... 2 
Table of contents ............................................................................................................................................. 3 
Background as provided by the European Commission .................................................................................. 4 
Terms of reference as provided by the European Commission ....................................................................... 4 
Assessment....................................................................................................................................................... 6 
1. Introduction ............................................................................................................................................. 6 
2. Definition/category ................................................................................................................................. 6 
2.1. Chemistry ....................................................................................................................................... 6 
2.2. Function, physiology and metabolism ............................................................................................ 6 
2.3. Biomarkers ..................................................................................................................................... 7 
3. Dietary sources and intake data .............................................................................................................. 8 
3.1. Dietary sources ............................................................................................................................... 8 
3.2. Dietary intakes ................................................................................................................................ 8 
4. Overview of Dietary Reference Values and recommendations .............................................................. 9 
4.1. Adults ............................................................................................................................................. 9 
4.2. Infants and children ........................................................................................................................ 9 
4.3. Pregnancy and lactation................................................................................................................ 10 
5. Criteria (endpoints) on which to base Dietary Reference Values ......................................................... 11 
5.1. Indicators of pantothenic acid requirement .................................................................................. 11 
5.2. Pantothenic acid intake and health consequences ........................................................................ 11 
5.3. Specific considerations during pregnancy and lactation .............................................................. 12 
6. Data on which to base Dietary Reference Values ................................................................................. 12 
6.1. Adults ........................................................................................................................................... 12 
6.2. Infants, children and adolescents ................................................................................................. 12 
6.3. Pregnancy and lactation................................................................................................................ 13 
Conclusions .................................................................................................................................................... 13 
Recommendations for research ...................................................................................................................... 13 
References ...................................................................................................................................................... 13 
Appendices .................................................................................................................................................... 18 
Appendix A. Pantothenic acid concentration of human milk from healthy mothers .............................. 18 
Appendix B. Pantothenic acid intake among children and adolescents in European countries .............. 20 
Appendix C. Pantothenic acid intake among adults aged ~ 19–65 years in European countries ........... 22 
Appendix D. Pantothenic acid intake among adults aged ~ 65 years and over in European countries .. 24 
Abbreviations ................................................................................................................................................. 25 
Dietary Reference Values for pantothenic acid 
 
EFSA Journal 2014;12(2):3581 4 
BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European Community 
dates from 1993. There is a need to review and if necessary to update these earlier recommendations to 
ensure that the Community action in the area of nutrition is underpinned by the latest scientific advice.  
In 1993, the SCF adopted an opinion on the nutrient and energy intakes for the European Community
4
. The 
report provided Reference Intakes for energy, certain macronutrients and micronutrients, but it did not 
include certain substances of physiological importance, for example dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on recommended 
dietary intakes. For a number of nutrients these newly established (national) recommendations differ from 
the reference intakes in the SCF (1993) report. Although there is considerable consensus between these 
newly derived (national) recommendations, differing opinions remain on some of the recommendations. 
Therefore, there is a need to review the existing EU Reference Intakes in the light of new scientific 
evidence, and taking into account the more recently reported national recommendations. There is also a 
need to include dietary components that were not covered in the SCF opinion of 1993, such as dietary 
fibre, and to consider whether it might be appropriate to establish reference intakes for other (essential) 
substances with a physiological effect. 
In this context the EFSA is requested to consider the existing Population Reference Intakes for energy, 
micro- and macronutrients and certain other dietary components, to review and complete the SCF 
recommendations, in the light of new evidence, and in addition advise on a Population Reference Intake 
for dietary fibre.  
For communication of nutrition and healthy eating messages to the public it is generally more appropriate 
to express recommendations for the intake of individual nutrients or substances in food-based terms. In this 
context the EFSA is asked to provide assistance on the translation of nutrient based recommendations for a 
healthy diet into food based recommendations intended for the population as a whole.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No 178/2002,
5
 the Commission 
requests EFSA to review the existing advice of the Scientific Committee for Food on population reference 
intakes for energy, nutrients and other substances with a nutritional or physiological effect in the context 
of a balanced diet which, when part of an overall healthy lifestyle, contribute to good health through 
optimal nutrition.  
In the first instance the EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically advice is requested on the following dietary components:  
 Carbohydrates, including sugars; 
 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty acids, 
trans fatty acids; 
                                                     
4  Scientific Committee for Food, Nutrient and energy intakes for the European Community, Reports of the Scientific Committee 
for Food 31st series, Office for Official Publication of the European Communities, Luxembourg, 1993. 
5  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1-24. 
Dietary Reference Values for pantothenic acid 
 
EFSA Journal 2014;12(2):3581 5 
 Protein; 
 Dietary fibre. 
Following on from the first part of the task, the EFSA is asked to advise on population reference intakes of 
micronutrients in the diet and, if considered appropriate, other essential substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition. 
Finally, the EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal nutrition 
(food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
In 1993, the Scientific Committee for Food (SCF) adopted an opinion on the nutrient and energy intakes 
for the European Community but was unable to define a specific physiological requirement of pantothenic 
acid for human health (SCF, 1993). The SCF noted that average intakes in adults were about 4–7 mg/day, 
but that individuals consumed from 3 to 12 mg/day. The SCF proposed an Acceptable Range of Intakes of 
pantothenic acid for adults of 3–12 mg/day, which was considered adequate to meet requirements and 
prevent deficiency. The SCF considered that there was no information on which to base additional 
requirements for pantothenic acid in pregnancy or lactation. The SCF did not set reference values for 
infants and children. 
2. Definition/category 
2.1. Chemistry 
Pantothenic acid
6
 is a water-soluble vitamin which is synthesised by microorganisms via an amide linkage 
of β-alanine and D-pantoic acid (Trumbo, 2014). The only form found in nature that is biologically active 
is D-pantothenic acid. The molecular mass of pantothenic acid is 219.23 Da. Pantothenic acid can be 
quantified in food and human tissues by well-established methods (IOM, 1998; Mittermayer et al., 2004; 
Pakin et al., 2004; Andrieux et al., 2012; Trumbo, 2014). 
2.2. Function, physiology and metabolism 
Pantothenic acid is a component of coenzyme A (CoA) and acyl-carrier proteins and serves in acyl-group 
activation and transfer, which is essential for fatty acid synthesis and oxidative degradation of fatty acids 
and amino acids. Humans cannot synthesise pantothenic acid and depend on its dietary intake.  
Dietary CoA is hydrolysed in the intestine to dephospho-CoA, phosphopantetheine and pantetheine. 
Pantetheine is further hydrolysed to pantothenic acid (Trumbo, 2014). Intestinal absorption of pantothenic 
acid occurs via a saturable sodium-dependent carrier-mediated process, which predominates over passive 
diffusion at physiological concentrations (Stein and Diamond, 1989; Prasad et al., 1999). There are few 
quantitative data on pantothenic acid absorption. A mean absorption efficiency of 50 % (range 40–61 %) 
of dietary pantothenic acid was estimated based on urinary pantothenic acid excretion of six healthy young 
men (Tarr et al., 1981). Although intestinal microbiota produce pantothenic acid, the extent to which it is 
absorbed from the large intestine and contributes to pantothenic acid requirements is uncertain (Trumbo, 
2014).  
In blood, pantothenic acid is transported mainly as CoA within erythrocytes (Trumbo, 2014). Pantothenic 
acid uptake in tissues occurs through an active sodium-dependent mechanism. Most of the pantothenic acid 
in tissues is present as CoA, mainly found in mitochondria, with lesser amounts present as acyl-carrier 
protein and free pantothenic acid. Pantothenic acid is excreted in urine, after hydrolysis of CoA in a 
multistep reaction. In a few groups of healthy subjects, average daily urinary excretion of pantothenic acid 
was observed to range between about 2.0 and 3.5 mg/day in children and adolescents (Schmidt, 1951; 
Kathman and Kies, 1984; Eissenstat et al., 1986) and between about 2.0 mg and 4.0 mg/day in adults 
(Schmidt, 1951; Fox and Linkswiler, 1961; Fry et al., 1976; Kathman and Kies, 1984; Song et al., 1985). 
Urinary excretion of pantothenic acid is positively correlated with pantothenic acid intakes (see Section 
2.3). 
                                                     
6 Also called vitamin B5. 
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Placental transport of pantothenic acid has been suggested to involve an active mechanism (Grassl, 1992; 
Wang et al., 1999). 
The concentration of pantothenic acid in mature human milk has been shown to correlate with maternal 
intake and urinary excretion of the vitamin (Song et al., 1984). Mean concentrations of pantothenic acid in 
mature human milk typically range between 2 and 3 mg/L (data from the UK, USA and Japan, up to one 
year of lactation) (DHSS, 1977; Ford et al., 1983; Song et al., 1984; Sakurai et al., 2005), although a mean 
concentration up to 6.7 mg/L has been found in a group of mothers in the USA taking or not supplements 
(Johnston et al., 1981) (Appendix A).  
Pantothenic acid is ubiquitous in foods and dietary deficiency is rare. Deficiency symptoms have been 
described in subjects on a pantothenic acid antagonist and/or pantothenic acid-deficient diet and include 
mood changes, as well as sleep, neurological, cardiac and gastrointestinal disturbances (Smith and Song, 
1996; SCF, 2002; Trumbo, 2014). 
The SCF noted that pantothenic acid has a low toxicity (SCF, 2002). A Tolerable Upper Intake Level (UL) 
for pantothenic acid could not be derived but evidence available from clinical studies using high doses of 
pantothenic acid (up to 2 g/day) indicates that intakes considerably in excess of observed levels of intake 
from all sources do not represent a health risk for the general population (SCF, 2002). 
Although biotin and pantothenic acid have been shown to share common carrier-mediated uptake 
mechanisms in vitro (Said, 2009), nutritional implications of this interaction are not known. 
2.3. Biomarkers 
Positive linear correlations (range of correlation coefficients (r) 0.3–0.6) between pantothenic acid intakes 
(range of means 4.8–6.3 mg/day) and 24-hour urinary excretion have been reported in groups (n = 37 to 
156, depending on study) of male and female adolescents (Eissenstat et al., 1986), pregnant, lactating and 
non-pregnant, non-lactating women (Song et al., 1985), male and female schoolchildren (Tjusi et al., 
2011), young men and women (Tjusi et al., 2010b) and elderly women (Tjusi et al., 2010a). No differences 
in urinary excretion were observed between sexes despite intakes being significantly higher in adolescent 
males than in adolescent females (Eissenstat et al., 1986), whereas the influence of sex was not 
investigated in other mixed populations (Tjusi et al., 2010b, 2011). 
In intervention trials with small groups of young women (n = 6–8), linear dose-response relationships have 
been described in subjects consuming a self-selected diet (6.7 ± 2.1 mg/day) or given doses of 2.8, 7.8 and 
12.8 mg/day of pantothenic acid for 10-day periods (r = 0.8) (Fox and Linkswiler, 1961) and 9.3 mg, 
14.1 mg, 24.3 mg and 40.7 mg for 4-day periods (r = 0.95) (Fukuwatari and Shibata, 2008). In both studies, 
urinary excretion was observed to be lower (30–60 %) than intake at all doses tested, except at the lowest 
intake of 2.8 mg/day, at which the mean urinary excretion was 3.2 mg/day. Upon depletion with a 
pantothenic acid-free diet for nine weeks, urinary excretion decreased to 0.79 ± 0.17 mg/day in six men 
compared with a urinary pantothenic acid excretion of 3.05 ± 1.20 mg/day at baseline at intakes of 
6.45 mg/day (range 4.85–8.16 mg/day) (Fry et al., 1976).  
In the study in adolescents by Eissenstat et al. (1986), positive correlations were also reported between 
pantothenic acid intakes and its concentrations in erythrocytes (r = 0.65) or in whole blood (r = 0.38) 
(mean intake of about 5 mg/day from food only). No differences in pantothenic acid concentration in 
erythrocytes or whole blood were observed between sexes. A positive correlation between pantothenic 
acid intakes and its concentrations in whole blood has also been observed in non-institutionalised older 
adults (mean intake of about 11 mg/day from food and supplements) (r = 0.38), but not in institutionalised 
subjects (Srinivasan et al., 1981).  
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In a group of six men depleted in pantothenic acid for nine weeks, pantothenic acid concentration in whole 
blood was found to be less sensitive to changes in intake than urinary concentration of pantothenic acid 
(Fry et al., 1976).  
Plasma/serum concentrations of pantothenic acid have been reported not to correlate with dietary intakes 
(Song et al., 1985; IOM, 1998). 
The Panel notes that urinary pantothenic acid excretion reflects recent pantothenic acid intake and that 
moderate correlations have also been observed between pantothenic acid intakes and its concentrations in 
whole blood or erythrocytes. However, data from the general population are limited so that the variability 
characteristics of these biomarkers and their ability to discriminate between pantothenic acid insufficiency 
and adequacy are not well known. No cut-off values have been established for these biomarkers. 
3. Dietary sources and intake data 
3.1. Dietary sources 
Pantothenic acid is present in a wide variety of foods. Foods rich in pantothenic acid include meat 
(products), eggs, nuts, avocados and cruciferous vegetables (FSA, 2002; Anses/CIQUAL, 2012). The main 
contributors to pantothenic acid intakes include meat products, bread, milk-based products and vegetables 
(Afssa, 2009; DGE, 2012). 
Currently, pantothenic acid (as D-pantothenate, calcium; D-pantothenate, sodium or dexpanthenol) may be 
added to foods
7
 and food supplements.
8
 The pantothenic acid content of infant and follow-on formulae is 
regulated.
9
 
3.2. Dietary intakes  
Estimates of pantothenic acid intakes in children and adolescents, adults and older adults from eight EU 
countries (Austria, France, Germany, Hungary, Ireland, Poland, Portugal and Latvia, data collected 
between 1996 and 2010) are provided in Appendices B, C and D, respectively. Values were calculated 
from individual consumption data collected from dietary history, three-/four-/seven-day dietary records, 
24-hour recall or food frequency questionnaires, combined with analytical data from food composition 
tables. Dietary intake data are prone to reporting errors and there is a varying degree of under-reporting in 
different surveys (Merten et al., 2011). Although the differences in methodologies have an impact on the 
accuracy of between-country comparisons, the data presented give an overview of the pantothenic acid 
intake in a number of European countries. 
Data in young children are limited to a survey in Irish children aged 1–4 years using four-day weighed 
dietary records, in which a median pantothenic acid intake of 4.1 mg/day was observed (IUNA, online-c). 
In boys and girls aged 3–12 years, mean/median intakes of 3.0 to 5.7 mg/day were reported. Median 
intakes ranged from 3.9 to 4.6 mg/day in France (3–10 years), from 4.4 to 5.7 mg/day in Ireland (5–12 
years) and from 4.0 to 4.3 mg/day in Germany (6–11 years), while mean intakes ranged from 3.0 to 
4.0 mg/day in Austria (7–12 years). 
                                                     
7  Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins 
and minerals and of certain other substances to foods, OJ L 404, 30.12.2006, p. 26.  
8
  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the 
Member States relating to food supplements, OJ L 183, 12.7.2002, p. 51.  
9  Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 
1999/21/EC, OJ L 401, 30.12.2006, p.1. 
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In adolescent boys and girls aged 11–19 years, mean/median intakes of 3.0 to 7.2 mg/day were reported. 
Median intakes ranged from 4.0 to 5.2 mg/day in France (11–17 years), from 4.2 to 6.6 mg/day in Ireland 
(13–17 years) and from 5.5 to 7.2 mg/day (12–17 years, using the dietary history method) or from 3.1 to 
4.0 mg/day (15–19 years, using 24-hour recalls) in Germany, while mean intakes ranged from 3.0 to 
6.0 mg/day in Austria (13–19 years). 
In adult men and women below about 65 years, mean/median intakes of 3.2 to 6.3 mg/day were reported. 
Data from France, Germany and Ireland indicated median intakes between 4.2 mg/day and 6.3 mg/day in 
men and between 3.3 and 5.2 mg/day in women, while data in Austria, Hungary and Portugal indicated 
mean intakes of 4.0 to 5.4 mg/day in men and 3.2 to 4.7 mg/day in women.  
In older men and women, mean/median intakes of 2.2 to 6.0 mg/day were reported. Data from France, 
Germany and Ireland indicated median intakes ranging from 4.2 to 6.0 mg/day in men and from 3.6 to 
5.2 mg/day in women, while data in Austria, Hungary, Poland and Portugal indicate mean intakes of 
between 2.6 to 4.7 mg/day in men and between 2.2 and 4.4 mg/day in women.  
Data on pantothenic acid intakes in pregnancy are scarce. Some intake estimates are available from 
observational studies conducted in the USA, the UK and Japan. In a population of Caucasian women in the 
USA, Song et al. (1985) observed a mean (± SD) pantothenic acid intake of 5.3 (± 1.7) mg/day during the 
third trimester of pregnancy (n = 26) and of 4.8 (± 1.6) mg/day in non-pregnant women (n = 17). In a study 
in Japanese women, Shibata et al. (2013) reported mean ( ± SD) pantothenic acid intakes of 
5.7 (± 2.1) mg/day (second trimester, n = 24) and 5.7 (± 1.7) mg/day (third trimester, n = 32) in pregnant 
women and 5.0 (± 1.5) mg/day in non-pregnant women (n = 37). In a cohort of 42 pregnant women in the 
UK, mean (± SD) pantothenic acid intakes of 3.7 (± 1.2) mg/day, 3.9 (± 1.2) mg/day, 3.9 (± 1.0) mg/day 
and 3.6 (± 1.1) mg/day during the first, second and third trimesters of pregnancy and six weeks post 
partum, respectively, were observed, using four- to seven-day weighed dietary records (Derbyshire et al., 
2009).   
4. Overview of Dietary Reference Values and recommendations 
Several national and international authorities have proposed reference values or recommendations for 
pantothenic acid intakes. There has been consensus so far that evidence is lacking to establish an Average 
Requirement (AR) for pantothenic acid. Rather, Adequate or Acceptable Ranges of Intakes have been 
proposed (Table 1). The Nordic countries did not set a reference value for pantothenic acid intake (NNR, 
2012). 
4.1. Adults 
The SCF (1993) and the UK Committee on Medical Aspects of Food Policy (COMA) (DH, 1991) set 
Acceptable Ranges of Intakes and the US Institute of Medicine (IOM, 1998), the French Food Safety 
Agency (Afssa, 2001), the World Health Organization / Food and Agriculture Organization of the United 
Nations (WHO/FAO, 2004) and the German-speaking countries (D-A-CH, 2013) set Adequate Intakes 
(AIs), based on data from dietary intake surveys, considering the absence of deficiency at observed 
intakes. IOM also noted that the proposed AI was supported by the limited data available on the dose-
response relationship between pantothenic acid intake and urinary excretion, which indicate that a 
pantothenic acid intake of approximately 4 mg/day would result in a similar amount of urinary excretion 
(Fox and Linkswiler, 1961).  
4.2. Infants and children 
The German-speaking countries (D-A-CH, 2013), WHO/FAO (2004) and Afssa (2001) proposed AIs for 
infants aged 7–12 months based on extrapolation from typical pantothenic acid intakes with human milk in 
younger exclusively breast-fed infants. Following the same approach, IOM (1998) estimated a value of 
Dietary Reference Values for pantothenic acid 
 
EFSA Journal 2014;12(2):3581 10 
2.2 mg/day, while a value of 1.4 mg/day was obtained by downward extrapolation of the AI for adults 
using allometric scaling (body weight to the power of 0.75 and reference body weights) and allowing for 
the needs for growth by addition of a growth factor; thus, an AI of 1.8 mg/day was set for infants aged 7–
12 months, being the mean of both values. 
The German-speaking countries derived AIs for children by interpolation between the values for infants 
and adults (D-A-CH, 2013), while Afssa (2001) estimated it based on the AI set for adults and correcting 
for the energy requirements of each age group. 
IOM (1998) extrapolated the AIs for children and adolescents from the AI of adults using allometric 
scaling and allowing for the needs for growth by the addition of a growth factor, which resulted in values 
consistent with available observed intakes for these age groups and intakes associated with blood and 
urinary pantothenic acid concentrations considered adequate (i.e. falling in typically observed ranges).  
4.3. Pregnancy and lactation 
The German-speaking countries (D-A-CH, 2013), Afssa (2001) and the UK COMA (DH, 1991) considered 
the AI set for adults to be sufficient to cover the period of pregnancy. WHO/FAO (2004) and IOM (1998) 
noted some evidence of lower whole blood pantothenic acid concentrations in pregnant women compared 
to non-pregnant women, although no differences in urinary excretion were observed and average intakes 
were found to exceed excretion (Song et al., 1985). The IOM (1998) set an AI of 6 mg/day based on 
observed average intakes in pregnant women (Song et al., 1985) and rounding up. 
WHO/FAO (2004), Afssa (2001) and IOM (1998) proposed an AI of 7 mg/day for lactating women, to 
compensate for losses through breast milk. D-A-CH (2013) and the UK COMA (DH, 1991) considered the 
AI set for adults to be sufficient to cover the period of lactation. 
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Table 1:  Overview of Dietary Reference Values for pantothenic acid 
 D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(1998)
 
SCF 
(1993) 
DH 
(1991) 
Infants       
Age (months) 4–<12 7–12 0–12 7–12   
AI (mg/day) 3 1.8 2 1.8 – – 
Children and adolescents     
Age (years) 1–<4 1–3 1–3 1–3   
AI (mg/day) 4 2 2.5 2 – – 
Age (years) 4–<7 4–6 4–6 4–8   
AI (mg/day) 4 3 3 3 – – 
Age (years) 7–<10 7–9 7–9 9–13   
AI (mg/day) 5 4 3.5 4 – – 
Age (years) 10–<13 10–18 10–12 14–18   
AI (mg/day) 5 5 4 5 – – 
Age (years) 13–<19  13–15    
AI (mg/day) 6 – 4.5 – – – 
Age (years)   16–19    
AI (mg/day) – – 5 – – – 
Adults       
Age (years) ≥ 19 ≥ 19 > 19 ≥ 19  ≥ 19 ≥ 19 
AI (mg/day) 6 5 5 5 3–12 (a) 3–7 (a) 
Pregnancy       
AI (mg/day) 6 6 5 6 3–12 (a) 3–7 (a) 
Lactation       
AI (mg/day) 6 7 7 7 3–12 (a) 3–7 (a) 
(a): Acceptable Range of Intakes. 
5. Criteria (endpoints) on which to base Dietary Reference Values 
5.1. Indicators of pantothenic acid requirement 
The Panel considers that there is no suitable biomarker to derive the AR for pantothenic acid.  
5.2. Pantothenic acid intake and health consequences 
Data examining the relationship between pantothenic acid intake and health outcomes are scarce.  
A comprehensive search of the literature published between January 1990 and December 2011 was 
performed as preparatory work to this assessment to identify relevant health outcomes upon which DRVs 
for pantothenic acid may potentially be based (El-Sohemy et al., 2012). Five observational studies were 
retrieved, which considered the relationship between pantothenic acid intake and health outcomes 
including genome damage (one cross-sectional study by Fenech et al. (2005)), birth outcomes (two 
prospective studies (Lagiou et al., 2005; Haggarty et al., 2009)), blood pressure (one cross-sectional study 
by Schutte et al. (2003)) and Parkinson’s disease (one case-control study by Hellenbrand et al. (1996)).  
The Panel considers that the data available from these studies are very limited and cannot be used for 
deriving DRVs for pantothenic acid. 
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5.3. Specific considerations during pregnancy and lactation 
Two small cohort studies in pregnant and lactating women and non-pregnant, non-lactating women provide 
data on pantothenic acid intakes as well as urinary pantothenic acid excretion (Song et al., 1985; Shibata et 
al., 2013) and whole blood pantothenic acid concentration (Song et al., 1985). Mean pantothenic acid 
intakes were between 5.3 and 6.2 mg/day in pregnant and lactating women and between 4.8 and 
5.0 mg/day in controls. In both studies, average urinary pantothenic acid excretion levels were lower than 
intakes in all groups of women. Results were inconsistent with respect to differences in urinary excretion 
of pantothenic acid between pregnant or lactating and non-pregnant, non-lactating women. Song et al. 
(1985) observed that concentrations of pantothenic acid in whole blood were significantly lower in 
pregnant and lactating women than in non-pregnant, non-lactating women, and significantly lower in 
pregnant women than in lactating women. The Panel concludes that data on biomarkers in pregnant and 
lactating women are scarce and provide inconsistent results and cannot be used to infer on a difference in 
the pantothenic acid status of pregnant and lactating women compared with non-pregnant, non-lactating 
women. 
Assuming an average breast milk pantothenic acid concentration of 2.5 mg/L (see Section 2.2) and an 
average breast milk secretion of 0.8 L/day over the first six months of lactation (Butte et al., 2002; 
FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009), the Panel notes that mean pantothenic acid secretion in 
milk is 2 mg/day in fully breast-feeding women.  
6. Data on which to base Dietary Reference Values 
The Panel considers that the available data are insufficient to derive ARs and PRIs for pantothenic acid, 
and therefore proposes to set an AI for all population groups. The setting of an AI for pantothenic acid is 
based on observed pantothenic acid intakes with a mixed diet and the apparent absence of signs of 
deficiency in the EU, suggesting that current intake levels are adequate. There is no indication that the AI 
should differ according to sex. 
6.1. Adults 
The Panel decided to use the approximate midpoint of the observed median/mean intakes (Appendices C 
and D) to set an AI for pantothenic acid at 5 mg/day for adults of all ages.  
6.2. Infants, children and adolescents 
Assuming an average breast milk pantothenic acid concentration of 2.5 mg/L (see Section 2.2.) and an 
average breast milk intake of exclusively breast-fed infants aged zero to six months of 0.8 L/day (Butte et 
al., 2002; FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009), the estimated intake of infants aged zero to 
six months is about 2 mg/day. The AI for infants over six months of age can be derived by extrapolation 
from this figure, using allometric scaling (body weight to the power of 0.75) and reference body weight for 
each age group
10
 (WHO Multicentre Growth Reference Study Group, 2006), in order to account for the 
role of pantothenic acid in energy metabolism, and rounding to the nearest unit. The AI for infants aged 7–
11 months is set at 3 mg/day.  
The Panel sets an AI for pantothenic acid of 4 mg/day for young and older children and of 5 mg/day for 
adolescents (Table 2), based on the approximate midpoints of the observed median/mean intakes of each 
age group (Appendix B).  
                                                     
10  Mean of body weight-for-age at 50th percentile of male and female infants aged three and nine months. 
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6.3. Pregnancy and lactation 
The Panel considers that data are insufficient to derive a specific AI for pantothenic acid in pregnancy. The 
Panel considers that the AI for adults of 5 mg/day also applies to pregnant women.  
Considering average pantothenic acid losses through breast milk of 2 mg/day during lactation (see 
Section 5.3), the Panel proposes to increase the AI for lactating women to 7 mg/day.  
CONCLUSIONS 
The Panel concludes that there is insufficient evidence to derive an Average Requirement (AR) and a 
Population Reference Intake (PRI) for pantothenic acid. Suitable data on pantothenic acid intake or status 
and health outcomes were not available for the setting of DRVs for pantothenic acid. Thus, the Panel 
proposes an Adequate Intake (AI) for adults based on observed intakes. It was considered unnecessary to 
give sex-specific values. The Panel proposes that the adult AI also applies to pregnant women. For 
lactating women, an increment in the adult AI is proposed, in order to compensate for pantothenic acid 
losses through secretion of breast milk. An AI is also proposed for infants aged 7–11 months based on 
extrapolation from the estimated intake of infants aged zero to six months using allometric scaling, and for 
children and adolescents based on observed intakes. 
Table 2:  Summary of Adequate Intakes for pantothenic acid 
Age Adequate Intake (mg/day) 
7–11 months 3 
1–3 years 4 
4–10 years 4 
11–17 years 5 
≥ 18 years (a) 5 
Lactation 7 
(a): Including pregnancy. 
RECOMMENDATIONS FOR RESEARCH  
The Panel recommends further research on pantothenic acid biomarkers that could be used to characterise 
the adequacy of pantothenic acid status in relation to physiological functions of the vitamin and allow the 
estimation of pantothenic acid requirements in various population groups. 
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APPENDICES 
Appendix A.  Pantothenic acid concentration of human milk from healthy mothers 
Reference Number of women 
(number of samples) 
Country Total maternal 
intake (mg/day), 
mean 
Stage of 
lactation 
Pantothenic acid concentration (mg/L) Method of analysis 
Mean ± SD Range 
DHSS (1977) (as 
reported by Picciano 
(1995)) 
96 (pooled sample from 
five cities) 
UK Not reported Not reported 2.2 n.a. Not reported 
Ford et al. (1983)  35 UK Not reported 
(a) 
 1–5 days 
6–15 days 
16–244 days 
1.26 
2.07 
2.61 
0.48–1.80 
0.42–3.23 
1.80–3.70 
‘Standard 
microbiological 
methods’ 
Sakurai et al. (2005)   (6) 
  (6) 
  (44) 
  (34) 
  (34) 
  (57) 
  (67) 
(119) 
Japan Not reported 
(b) 
 6–10 days 
11–20 days 
21–89 days 
90–180 days 
181–365 days 
Summer 
Winter 
Overall 
2.0 ± 1.0 
2.6 ± 0.8 
2.9 ± 0.8 
2.8 ± 1.1 
2.6 ± 0.8 
2.6 ± 0.9 
2.8 ± 0.9 
2.7 ± 0.9 
n.a. Microbiological assay 
(Lactobacillus 
arabinosus) 
Johnston et al. (1981)  22 
 (13) 
 (14) 
 (16) 
 (14) 
 (12) 
 (11) 
 
USA 5.4–26.6 (c)  
1 month 
2 months 
3 months 
4 months 
5 months 
6 months 
Overall 
 
7.1 
7.6 
6.6 
6.8 
6.1 
5.8 
6.7  
1.8–16.7 Microbiological assay 
(Lactobacillus 
plantarum) 
Song et al. (1984)  26 
 
 (22) 
 (24) 
USA 5.9 ± 2.0 
(d)
 
32.4 ± 24.6 
(e)
 
 
 
2 weeks 
3 months 
 
 
2.57 ± 0.60 
2.55 ± 0.73 
n.a. Radioimmunoassay 
(a): No indication of supplementation. 
(b): Not taking supplements. 
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(c): Three mothers were taking supplements at one month, two at two months, one at four months, none at five months and two at six months. Over the six months of the study, 5.4 mg/day is 
the lowest mean provided by diet alone, while 26.6 mg/day is the highest mean provided by diet and supplements. 
(d): Not taking supplements (n = 46). 
(e): Taking supplements (n = 6). 
n.a., not available.  
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Appendix B. Pantothenic acid intake among children and adolescents in European countries 
Country Reference Dietary assessment method (year of survey) 
(a)
 Age 
(years) 
n Mean 
(mg/day) 
SD Median  
(mg/day) 
P5–P95 
Boys      n.a. n.a. n.a. 
Austria Elmadfa et al. (2009) Seven-day record (2003) 7–9 n.a. 4.0 n.a. n.a. n.a. 
   10–12 n.a. 4.0 n.a. n.a. n.a. 
   13–15 n.a. 4.0 n.a. n.a. n.a. 
  Three-day record (2007–2008) 7–9 148 4.0 n.a. n.a. n.a. 
   10–12 155 4.0 n.a. n.a. n.a. 
   13–15 86 4.0 n.a. n.a. n.a. 
  24-hour recall (2004) (Berufsschüler/allgemeinbildende 
höhere Schulen-Schüler) 
14–19 35/47 6.0/5.0 n.a. n.a. n.a. 
France Afssa (2009) Seven-day record (2006–2007) 3–10 n.a. 4.7 1.7 4.6 n.a. 
   11–14 n.a. 5.5 1.6 5.2 n.a. 
   15–17 n.a. 5.5 1.6 5.2 n.a. 
Germany
 Mensink et al. (2007) Three-day record (2006) 6–11 626 n.a. n.a. 4.3 2.6–8.7 
 Mensink et al. (2007) Dietary history (over the last four weeks) (2006) 12–17 622 n.a. n.a. 7.2 3.5–17.4 
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 15–19 506 n.a. n.a. 4.0  
Ireland IUNA (online-a) Seven-day record (2003–2004) 5–8 145 5.4 2.2 5.1 2.6–9.8 
 IUNA (online-a) Seven-day record (2003–2004) 9–12 148 5.9 2.3 5.7 2.6–10.5 
 IUNA (online-b) Seven-day record (2005–2006) 13–14 95 7.0 3.9 5.9 3.3–13.0 
 IUNA (online-b) Seven-day record (2005–2006) 15–17 129 7.5 4.3 6.6 3.0–15.0 
Girls 
        
Austria Elmadfa et al. (2009) Seven-day record (2003) 7–9 n.a. 3.6 n.a. n.a. n.a. 
   10–12 n.a. 3.8 n.a. n.a. n.a. 
   13–15 n.a. 3.4 n.a. n.a. n.a. 
  Three-day record (2007–2008) 7–9 175 3.3 n.a. n.a. n.a. 
   10–12 152 3.3 n.a. n.a. n.a. 
   13–15 64 3.0 n.a. n.a. n.a. 
  24-hour recall (2004) (Berufsschüler/allgemeinbildende 
höhere Schulen-Schüler) 
14–19 28/39 4.0/4.0 n.a. n.a. n.a. 
France Afssa (2009) Seven-day record (2006–2007) 3–10 n.a. 4.2 1.2 3.9 n.a. 
   11–14 n.a. 4.5 1.3 4.5 n.a. 
   15–17 n.a. 4.3 1.4 4.0 n.a. 
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Country Reference Dietary assessment method (year of survey) 
(a)
 Age 
(years) 
n Mean 
(mg/day) 
SD Median  
(mg/day) 
P5–P95 
Germany
 Mensink et al. (2007) Three-day record (2006) 6–11 608 n.a. n.a. 4.0 2.0–7.8 
 Mensink et al. (2007) Dietary history (over the last four weeks) (2006) 12–17 650 n.a. n.a. 5.5 2.7–16.9 
 DGE (2012) Two non-consecutive 24-hour recalls (2005–2006) 15–19 536 n.a. n.a. 3.1  
Ireland IUNA (online-a) Seven-day record (2003–2004) 5–8 151 4.7 1.8 4.4 2.5–7.8 
 IUNA (online-a) Seven-day record (2003–2004) 9–12 150 5.1 3.8 4.5 2.3–9.0 
 IUNA (online-b) Seven-day record (2005–2006) 13–14 93 5.1 3.6 4.2 1.8–10.8 
 IUNA (online-b) Seven-day record (2005–2006) 15–17 124 5.3 4.2 4.4 1.8–11.1 
Both sexes 
       
Ireland IUNA (online-c) Four-day weighed dietary record (2010–2011) 1–4 500 4.5 1.8 4.1 2.4–8.0 
(a):  Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile. 
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Appendix C. Pantothenic acid intake among adults aged ~ 19–65 years in European countries 
Country Reference Dietary assessment method 
(year of survey) 
(a)
 
Age (years) n Mean 
(mg/day) 
SD Median 
(mg/day) 
P5–P95 
Men         
Austria Elmadfa et al. (2009) 24-hour recall 18–25 93 5.4 n.a. n.a. n.a. 
   25–51 541 4.7 n.a. n.a. n.a. 
   51–64 144 4.6 n.a. n.a. n.a. 
France Afssa (2009) Seven-day record (2006–2007) 18–34 n.a. 6.0 2.1 5.8 n.a. 
   35–54  6.6 1.9 6.3 n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–
2006) 
19–24 469 n.a. n.a. 4.2  n.a. 
  25–34 614 n.a. n.a. 4.4 n.a. 
  35–50 1 946 n.a. n.a. 4.5 n.a. 
  51–64 1 460 n.a. n.a. 4.5 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) 18–34 473 4.0 1.2 n.a. n.a. 
   35–59 136 4.1 1.2 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) 18–64 634 6.8 2.5 6.3 3.5–11.8 
Portugal Lopes et al. (2006) Food frequency questionnaire (1999–2003). Data 
collected in Porto 
18–64 917 4.8 1.2 n.a. 3.0–7.0 
Women 
        
Austria Elmadfa et al. (2009) 24-hour recall 18–25 187 4.1 n.a. n.a. n.a. 
   25–51 959 4.4 n.a. n.a. n.a. 
   51–64 199 4.5 n.a. n.a. n.a. 
France Afssa (2009) Seven-day record (2006–2007) 18–34 n.a. 4.7 1.4 4.6 n.a. 
   35–54  5.3 1.4 5.2 n.a. 
Germany
 DGE (2012) Two 24-hour recalls (2005–2006) 19–24 486 n.a. n.a. 3.3 n.a. 
  25–34 852 n.a. n.a. 3.6 n.a. 
  35–50 2 648 n.a. n.a. 3.7 n.a. 
  51–64 1 740  n.a. 3.6 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) 18–34 176 3.2 0 n.a. n.a. 
   35–60 295 3.2 0 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) 18–64 640 5.0 1.9 4.7 2.4–8.2 
Portugal  Lopes et al. (2006) Food frequency questionnaire (1999–2003). Data 
collected in Porto 
18–64 1 472 4.7 1.3 n.a. 2.8–7.0 
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Country Reference Dietary assessment method 
(year of survey) 
(a)
 
Age (years) n Mean 
(mg/day) 
SD Median 
(mg/day) 
P5–P95 
Both sexes 
        
Latvia Joffe et al. (2009) Two non-consecutive 24-hour dietary recalls + 
food frequency questionnaire (2008) 
17–26 378 4.6 n.a. n.a. n.a. 
   27–36 206 4.8 n.a. n.a. n.a. 
   37–46 272 4.6 n.a. n.a. n.a. 
   47–56 304 4.7 n.a. n.a. n.a. 
   57–64 217 4.3 n.a. n.a. n.a. 
(a):  Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile.  
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Appendix D. Pantothenic acid intake among adults aged ~ 65 years and over in European countries 
Country Reference Dietary assessment method  
(year of survey
) (a)
 
Age (years) n Mean 
(mg/day) 
SD Median 
(mg/day) 
P5–P95 
Men         
Austria Elmadfa et al. (2009) Three-day record  (2007–2008) ≥ 55 121 3.8 n.a n.a n.a 
France Afssa (2009) Seven-day record (2006–2007) 55–79 n.a. 6.2 1.8 6.0 n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–
2006) 
65–80 1 165 n.a. n.a. 4.2 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) ≥ 60 138 3.5 1.2 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) ≥ 65 106 6.0 1.9 5.7 3.1–9.0 
Poland Przysławski (1999) 24-hour recall (1996–1997) ≥ 50 443 2.6 1.3 n.a. n.a. 
Portugal Lopes et al. (2006) Food frequency questionnaire (1999–2003). Data 
collected in Porto 
≥ 65 246 4.7 1.2 n.a. 3.0–6.8 
Women 
        
Austria Elmadfa et al. (2009) Three-day record  (2007–2008) ≥ 55 302 3.7 n.a n.a n.a 
France Afssa (2009) Seven-day record (2006–2007) 55–79 n.a. 5.1 1.3 4.9 n.a. 
Germany
 DGE (2012) Two non-consecutive 24-hour recalls (2005–
2006) 
65–80 1 331 n.a. n.a. 3.6 n.a. 
Hungary Zajkas et al. (2007) Three-day record (2003–2004) ≥ 60 235 2.9 1.1 n.a. n.a. 
Ireland IUNA (2011) Four-day record (2008–2010) ≥ 65 120 5.3 1.9 5.2 2.8–9.8  
 
Poland Przysławski (1999) 24-hour recall (1996–1997) ≥ 50 803 2.2 0.9 n.a. n.a. 
Portugal Lopes et al. (2006) Food frequency questionnaire (1999–2003). Data 
collected in Porto 
≥ 65 339 4.4 1.2 n.a. 2.6–6.5 
(a):  Supplements excluded. 
n.a., not available; P5, 5th percentile; P95, 95th percentile.  
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ABBREVIATIONS 
Afssa Agence française de sécurité sanitaire des aliments 
AI Adequate Intake 
Anses Agence nationale de sécurité sanitaire de l'alimentation, de 
l’environnement, et du travail 
AR Average Requirement 
CIQUAL Centre d'Information sur la Qualité des Aliments 
CoA coenzyme A 
COMA Committee on Medical Aspects of Food Policy 
D-A-CH Deutschland- Austria- Confoederatio Helvetica 
DGE Deutsche Gesellschaft für Ernährung 
DH Department of Health 
DRV Dietary Reference Value  
EC European Commission 
EFSA European Food Safety Authority 
EU European Union 
FAO Food and Agriculture Organization 
FSA Food Standards Agency 
IOM US Institute of Medicine of the National Academy of Sciences 
IUNA  Irish Universities Nutrition Alliance 
IUPAC International Union of Pure and Applied Chemistry 
NNR Nordic Nutrition Recommendations 
SCF Scientific Committee for Food 
SD standard deviation 
UL Tolerable Upper Intake Level 
UNU United Nations University 
WHO World Health Organization 
 
